Fabtech Technologies Ltd.

141.5

-8.4 (-5.6%)growUp

As on March 13, 2026
Sector
IndustryHealthcare Equipment & Supplies
Basic IndustryMedical Equipment & Supplies
Market Cap0 Cr
P/E Ratio9.87
Dividend Yield0.11 %
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open148.1
High148.11
NSE SymbolFABTECH
Close141.5
Low140.11
BSE Symbol544558
Previous Years High/Low
1 Year High262.8
3 Year High262.8
5 Year High262.8
1 Year Low134.42
3 Year Low134.42
5 Year Low134.42

Technicals


IndicatorsValueSignal
5-DMA146.88Bearish
10-DMA145.8Bearish
20-DMA151.54Bearish
50-DMA164.7Bearish
100-DMA196.8Bearish
200-DMA---

Historical Performance


1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


ParticularsMar-2025Mar-2024Mar-2023Mar-2022
Net Sales3,2672,2611,9382,572
Total Expenditure2,8791,9131,6872,250
Other Income93456127
Operating Profit480393312349
Interest32285131
Depreciation26211916
Profit Before Tax604358279314
Consolidated Net Profit465272217235
Adjusted EPS14878
Compounded Sales Growth
10 Years:4.9
5 Years:4.9
3 Years:4.9
TTM:7.6
Compounded Profit Growth
10 Years:14.6
5 Years:14.6
3 Years:14.6
TTM:11.3
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:7.1
last year:14.3

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


ParticularsMar-2025Mar-2024Mar-2023Mar-2022
Share Capital324292828
Total Reserves1,4071,289862646
Long-Term Borrowings------------
Total Non-Current Liabilities25571330
Other Current Liabilities661593345287
Short Term Borrowings53887331175
Total Liabilities4,2412,6752,1261,710
Capital Work in Progress------------
Long Term Loans & Advances36447829
Currents Investments6421011
Short Term Loans and Advances479295348256
Total Current Assets3,0822,2951,8091,465
Total Assets4,2412,6752,1261,710
Adjusted Book Value53412922
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a low PE of 9.87, which may indicate undervaluation or subdued growth expectations.
  • Over the last three years, the stock delivered price CAGR data is unavailable.
  • The stock carries a beta of 1.2, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹480 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹3267 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 775767.5
No. of Shares: 5482 (Approx)
Performance:-22.4%
P/L: ₹-224232.5
NIFTY Performance: 3.4%
1 day Top Gainers
SymbolChange%
LTTS3430.1(10%)
ACMESOLAR255.61(7%)
IFCI57.21(6%)
AIIL474.8(6%)
CHOLAHLDNG1553.9(5%)
1 Day Top Losers
SymbolChange%
CRAFTSMAN6674(-9%)
CEATLTD3470.5(-9%)
KPRMILL839.2(-8%)
LT3439(-8%)
AMBER6446(-7%)
ATGL565.9(-7%)
MRPL178.14(-7%)
PCBL253.2(-7%)

Top Performing Stocks from the same sector


Poly Medicure Ltd.

-2.2%

1260.2

1 Month Performance

Tarsons Products Ltd.

-3.8%

192.78

1 Month Performance

Laxmi Dental Ltd.

-7%

178.51

1 Month Performance

Nureca Ltd.

-8.5%

257.45

1 Month Performance

Fischer Medical Ventures Ltd.

-17.5%

34.06

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month